Author

I. Tsukalov

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

H. de la Fuente· 2 shared A. Alfranca· 1 shared A. Benguria Filippini· 1 shared A. Dopazo· 1 shared A. Ramiro· 1 shared A. Triguero Martinez· 1 shared C. Delgado Alfaro· 1 shared C. Delgado-Arevalo· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

H. de la Fuente

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintMar 13, 2022

Antiviral State of CD1c+ cDC contributes to Increased Maturation and Activation of Cytotoxic Natural Killer cells in Sjogrens Syndrome

I. Sanchez Cerrillo, M. Calvet Mirabent, A. Triguero Martinez…·E. Martin-Gayo

The paper identifies CD1c+ cDCs in pSS patients that enhance NK cell activation through antiviral IFN signatures and ligands for NK receptors, contributing to disease pathology.

DOI 10.1101/2022.03.13.484063

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintJan 14, 2022

ART duration and immunometabolic state determine efficacy of DC-based treatment restoring functional HIV- specific CD8+ T cells in PLWH.

M. Calvet-Mirabent, I. Sanchez-Cerrillo, N. Martin-Cofreces…·E. M.-G. Martin-Gayo

This study shows that ART duration affects CD8+ T cell function in HIV-1 patients, with longer ART improving DC-based immunotherapy outcomes through specific immunometabolic changes.

DOI 10.1101/2022.01.14.476403

humanproteomics

𝕏 PostBluesky